anti-abortion groups

Anti-abortion groups are increasing activism after a Medicaid funding ban for abortion providers like Planned Parenthood was excluded from Republicans’ reconciliation 3.0 framework. The omission threatens to heighten tensions between Republicans and anti-abortion activists, who are already criticizing the Trump administration for not leveraging executive authority.

Four years after the Dobbs decision, advocates clash over later abortion access as individuals like Erika Christensen and Kate Dineen share experiences of denied or restricted care due to gestational limits. While some clinics expand later abortion services, anti-abortion groups and Republican officials oppose such access, citing false claims about post-birth procedures, and advocates push to repeal 18-week bans in 21 states.

The Trump administration is shifting the federal Title X program, which traditionally provided contraception access, to emphasize childbearing and family formation. The new guidelines prioritize natural methods for avoiding pregnancy and addressing infertility, potentially harming low-income and minority women reliant on the program.

The Trump administration is shifting the Title X federal program, which traditionally provided access to contraception, to prioritize promoting childbearing and family formation. New guidelines emphasize natural pregnancy prevention methods, fertility education, and aligning with efforts to increase the U.S. birth rate, while prohibiting DEI initiatives and restricting abortion-related services.

The Trump administration is shifting the federal Title X program, which traditionally provided contraception access, to emphasize childbearing and family formation. New guidelines prioritize natural pregnancy prevention methods, infertility treatments, and 'body literacy education,' while prohibiting DEI efforts and linking funding to reduced immigration facilitation. Critics argue the changes will disproportionately harm low-income and minority women.

The Trump administration is overhauling the federal Title X program, shifting its focus from contraception to promoting family formation and fertility awareness. The new guidelines prioritize natural methods to prevent pregnancy and address infertility, while prohibiting DEI efforts and linking funding to immigration policies. Health policy researchers warn the changes may disproportionately harm low-income and minority women.

The Trump administration is shifting the federal Title X program, which traditionally provided access to contraception, toward promoting childbearing and family formation. New guidelines prioritize natural pregnancy prevention methods and address infertility, while prohibiting DEI efforts and linking funding to anti-immigration policies. Critics argue the changes will disproportionately harm low-income and minority women reliant on Title X services.

The Trump administration is shifting the federal Title X program, which provides contraception access, to emphasize family formation and healthy pregnancies. The change prioritizes natural pregnancy methods and opposes abortion, with critics arguing it will harm low-income and minority women reliant on the program.

The Trump administration is shifting the federal Title X program, which provides reproductive health services, to prioritize promoting childbearing and family formation over contraception access. New guidelines emphasize natural pregnancy prevention methods, fertility education, and aligning with efforts to boost the U.S. birth rate, while prohibiting DEI initiatives and linking funding to immigration restrictions. Critics argue the changes will disproportionately harm low-income and minority women.

Republican state representatives Eric Murphy of North Dakota and Richard Briggs of Tennessee faced primary challenges after introducing bills to modify their states' abortion restrictions. Anti-abortion groups and conservative allies campaigned against them, leading to lost endorsements and primary contests.

The FDA is conducting a safety review of the abortion drug mifepristone. This action could lead to restrictions on its use and distribution, supported by anti-abortion groups as a potential victory for their cause.